Published in Cancer Weekly, February 9th, 2010
There is a growing consensus among scientists that fulfilling the promise of molecular medicine requires a shift from the study of single events to viewing complex biological systems in their entirety. CRi's integrated imaging products provide researchers and clinicians with quantitative assessments of disease and drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2010-02-09)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.